Sionna Therapeutics, Inc.
7.48USD
+0.1800 (+2.47%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.67▲ | $-0.7 | 3 | 4 |
| Next quarter | $-0.62▲ | $-0.71 | 5 | 3 |
| Current year | $-2.56▼ | $-2.41 | 4 | 5 |
| Next year | $-2.53▲ | $-2.72 | 4 | 5 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.65 | $-0.66 | -0.01 (-2.0%) |
| 2026-03-31 | $-0.5 | $-0.6 | -0.10 (-19.1%) |
| 2025-12-31 | $-0.54 | $-0.46 | +0.08 (+14.0%) |
| 2025-09-30 | $-0.48 | $-0.46 | +0.01 (+3.2%) |
24 ratings from 10 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Guggenheim | Downgraded from Buy | Neutral | — | Aug 11, 2026 |
| Wedbush | Downgraded from Outperform | Neutral | $53 $5 | Aug 11, 2026 |
| BTIG | Downgraded from Buy | Neutral | — | Aug 10, 2026 |
| Guggenheim | Maintained | Buy | $50 $60 | Aug 7, 2026 |
| Citizens | Reiterated | Market Outperform | $63 | May 26, 2026 |
| Freedom Broker | Downgraded from Buy | Hold | $38 | May 20, 2026 |
| Stifel | Maintained | Buy | $44 $55 | May 18, 2026 |
| BTIG | Reiterated | Buy | $58 | May 13, 2026 |
| Wedbush | Initiated | Outperform | $53 | May 5, 2026 |
| Jones Trading | Maintained | Buy | $52 $63 | Apr 28, 2026 |
| BTIG | Reiterated | Buy | $58 | Apr 27, 2026 |
| Guggenheim | Maintained | Buy | $45 $50 | Mar 3, 2026 |
| BTIG | Reiterated | Buy | $58 | Mar 2, 2026 |
| Citizens | Initiated | Market Outperform | $63 | Feb 24, 2026 |
| BTIG | Reiterated | Buy | $58 | Jan 14, 2026 |
| BTIG | Maintained | Buy | $50 $58 | Jan 7, 2026 |
| LifeSci Capital | Initiated | Outperform | $60 | Dec 23, 2025 |
| RBC Capital | Downgraded from Sector Perform | Underperform | $24 | Dec 1, 2025 |
| BTIG | Initiated | Buy | $50 | Nov 19, 2025 |
| Freedom Broker | Initiated | Buy | $38 | Oct 17, 2025 |
| Jones Trading | Initiated | Buy | $46 | Sep 8, 2025 |
| Raymond James | Initiated | Strong Buy | $45 | Sep 3, 2025 |
| RBC Capital | Initiated | Sector Perform | $22 | Sep 3, 2025 |
| Stifel | Initiated | Buy | $32 | Mar 4, 2025 |
58 filings from 10 insiders · 1 buy / 12 sell over 6m
Officers and directors of SION, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| THOMPSON PETER ADirector | Sellindirect | 85.9k | $44.86 | $3.85M | Jul 7, 2026 |
| ORBIMED ADVISORS, L.L.C.Unknown | Sellindirect | 85.9k | $44.86 | $3.85M | Jul 7, 2026 |
| FITZPATRICK JENNIFER ROfficer | Exercise | 10.3k | $6.11 | $63k | Jul 6, 2026 |
| FITZPATRICK JENNIFER ROfficer | Sell | 10.3k | $43.60 | $447k | Jul 6, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 115.8k | $45.50 | $5.27M | Jun 30, 2026 |
| ORBIMED ADVISORS, L.L.C.Director | Sellindirect | 115.8k | $45.50 | $5.27M | Jun 30, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 101 | $44.49 | $4k | May 27, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 293.0k | $44.58 | $13.36M | May 11, 2026 |
| ORBIMED ADVISORS, L.L.C.Unknown | Sellindirect | 293.0k | $44.58 | $13.36M | May 11, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 55.3k | $44.52 | $2.47M | Apr 17, 2026 |
| ORBIMED ADVISORS, L.L.C.Unknown | Sellindirect | 55.3k | $44.52 | $2.47M | Apr 17, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 510.6k | $44.51 | $22.95M | Apr 16, 2026 |
| ORBIMED ADVISORS, L.L.C.Unknown | Sellindirect | 510.6k | $44.51 | $22.95M | Apr 16, 2026 |
| FITZPATRICK JENNIFER ROfficer | Exercise | 10.3k | $6.11 | $63k | Mar 5, 2026 |
| FITZPATRICK JENNIFER ROfficer | Sell | 10.3k | $33.86 | $347k | Mar 5, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 31.0k | $44.57 | $1.38M | Feb 3, 2026 |
| ORBIMED ADVISORS, L.L.C.Director | Sellindirect | 31.0k | $44.57 | $1.38M | Feb 3, 2026 |
| TPG GP A, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Sellindirect | 250.0k | $40.00 | $10.00M | Jan 22, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 33.4k | $44.55 | $1.49M | Dec 24, 2025 |
| ORBIMED ADVISORS, L.L.C.Director | Sellindirect | 33.4k | $44.55 | $1.49M | Dec 24, 2025 |
No analyst notes on SION yet.
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 10 | 0 | 0 | Hold2.91 |
| 1 mo ago | 1 | 8 | 1 | 0 | 1 | Buy2.27 |
| 2 mo ago | 1 | 8 | 1 | 0 | 1 | Buy2.27 |